ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000462.1|WLIP_1 # 92 # 1072 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.642	BGC0000462.1|WLIP_1 	92	1072	+	Loose	680	26.1794	LpeA	45.83	3004099	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGCGTTGTCTGTCCTGGACCTGGTCATGATCGGCGAGGGCAAGACCCTGGCCGATGCGATCGAGGAATCCCGCCAACTGGCACGTCACGTCGAGCAGCACGGTTACGCTCGATACTGGATCGCCGAACACCATGACATGCCCGGCATCGGCTCTGCCGCCACCGCGCTGGTAATCAACGAGATCGCCAATGCCACGCGGCATATTCGCGTGGGTGCCGGTGGCATCATGCTGCCCAATCATGCCCCGCTGGTGGTTGCCGAGCAGTTCGGTACGCTTGATACCTTGCATCCGGGGCGCATCGACCTGGGGCTGGGACGTGCCCCAGGCAGTTCCGGGCCGACCGTACGTGCGTTGCGCGGCGTCGCGCCCGAGCGTGACTTTGGCCAGGATATTGCCGAGCTGCGCGACTACCTGGCCGACAACGGCCAGCGATCGGTGCGCGGGGTGCCGGGCAAGCACGAGGTGCCGGTGTGGATATTGGGCTCCAGCCTGTTCGGTGCCGACCTTGCGGCCCGGCTCGGCTTGCCTTATGCCTTCGCCTCTCATTTCGCCCCGCGCTACCTGTTGCAGGCCATCGCCCATTACCGCGCGAACTTCCAACCCTCGGCGCAACTGGCCAAGCCCTACGTCATGGTGGGCATGAATCTGTTCGCTGCAGCCAGCGATGCCGAAGCCGATTACCTCGCCAGCTCGCACCGCAAATGGATGCTCGATCTGCATGTCGGACGTCATGGCCTGCTGCCCTTGCCGCAGGAAGGTTATGTCCAGGGTTTGCCGGGCCATGAACGAGCGGTGCTGGAGCAGGTGATGGCCTGTACCATAGTCGGCGGACCGCAGCGGGTGAGGGATGGGTTGCGCGCACTGATCGAACAGACTGGCGCCGATGAGTTGATGATCGATTGCCGGATCCATGACCCGTTGGCGCGCCTGCGCTCTCACGCGTATGCGGCGCAGGCCCTTGCCGACCTGAACTGA	MTALSVLDLVMIGEGKTLADAIEESRQLARHVEQHGYARYWIAEHHDMPGIGSAATALVINEIANATRHIRVGAGGIMLPNHAPLVVAEQFGTLDTLHPGRIDLGLGRAPGSSGPTVRALRGVAPERDFGQDIAELRDYLADNGQRSVRGVPGKHEVPVWILGSSLFGADLAARLGLPYAFASHFAPRYLLQAIAHYRANFQPSAQLAKPYVMVGMNLFAAASDAEADYLASSHRKWMLDLHVGRHGLLPLPQEGYVQGLPGHERAVLEQVMACTIVGGPQRVRDGLRALIEQTGADELMIDCRIHDPLARLRSHAYAAQALADLN	MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSHNLQQTIHLLGTIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQYERITPLIKSGYVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVSIYDPSALVVDFDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVELLVAEKNNTIVIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLYPEMTVDIYHPATSSS	91.83	gnl|BL_ORD_ID|2386|hsp_num:0	2758			207	279	erythromycin; spiramycin; azithromycin
BGC0000462.1|WLIP_2 # 1116 # 2513 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.655	BGC0000462.1|WLIP_2 	1116	2513	-	Loose	850	534.643	OprM	61.99	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCAAATACTCTGCTGCCTTGTTGGCGGTGTTGCTGACCGGCTGCACCCTGGCCCCCGACTATCAACGCCCCGCCCTGCCTGTCGCCCCTGAATTTCCCTTGGGGGAGACCACCCAGGCCGACATGACGCACGGCCATCAGCACGACGACTGGCACGAAGTGTTCCAGGATCCGTTGCTACGCCAATTGATCGATAACGCATTGCTCAACAACCGCGATCTGCGCGTCGCAGCGCTCAACGTCGAAGCCTATCGCGCGCAGTTTCGTATCCAGCGCTCGGAGTTGCTGCCCAAGGTGTCCGCCGACGCCAAGGGCCAGCGTCAGTACCTGCCGAGGCGCATGACCGGAACCGGTGAAGGCGCCATTACCCAGACCTACGCCGCCACGCTCGGGGTGAGCGCTTATGAGCTTGACCTGTTCGGCCGCCTGCGCAGCCTGAGCGACAAGGCCTTGCTGACCTACCTCGCCAGCGAACAGGCCCGACGCAGTGTGCAACTGGGGTTGGTGGCCAGCGTGGCCAGCAGCTACATGACCTGGCGTGCCGACCTGGAACTGCTCGAACTGTCACGCCAGACCCTGATCGCCGACCAGGAAAGCCTGCGCCTGACCCAAGGTCAGCGCCGCGCCGGCACTGCGTCGGCATTGCAGCAGATCCAGGCGCAGACCAGCGTCGACACCGCCCGTGCTGCAGTAGCGCGCTACCAGCGCCAGGTTGCCCAGGATATCAACCAGCTGACCCTGCTGGTCGGCGCGCCCCTCGATGAGCGCACGCCCAGCTTGCCGCTGGCCTCGCCACAGATCGTCGGTTTGCCAGCCGGCCTGCCCTCGGCACTGCTGCAGCGTCGCCCGGACATCCTCGAAGCCGAACACCAGTTGCGCGCCGCCAATGCCGACATCGGTGCTGCACGGGCGGCATTCTTCCCCAGTATCAGCCTGACCGCCAACGCTGGCAGCAGCAGTCGCGAGTTGTCCGGGCTGTTCGACGGCGGCACCGGAACCTGGTTGTTCCAGCCGCAGATCAACCTGCCACTGTTCACCGCCGGCAGCCTGCGGGCCAGCCTGGACTATGCACGCCTGCAAAAGGAAATCGAGGTCGCCCGCTACGAGAAATCGATTCAGGGCGCGTTCCAGGAGGTGTCTGACGGTCTGGCCGCGCGCGCCACGTATGAGCGGCAACTGGTGGCCCAACGCGACCTGGTGGCCTCTACACAGCGTTACTACGACCTGGCCCGCAACCGCTACCGCATTGGCGTGGACAGCAGCCTGACCTTTCTCGACGCCCAGCGCTCGCTGTTCAGCGCCCAGCAGGGGTTGATCAACGACCGGCTGGCGCAACTGCTGGCAGAGGTGAACCTCTATGCCGCGCTGGGCGGGGGCTGGAAAGACGCACAGTGA	MPKYSAALLAVLLTGCTLAPDYQRPALPVAPEFPLGETTQADMTHGHQHDDWHEVFQDPLLRQLIDNALLNNRDLRVAALNVEAYRAQFRIQRSELLPKVSADAKGQRQYLPRRMTGTGEGAITQTYAATLGVSAYELDLFGRLRSLSDKALLTYLASEQARRSVQLGLVASVASSYMTWRADLELLELSRQTLIADQESLRLTQGQRRAGTASALQQIQAQTSVDTARAAVARYQRQVAQDINQLTLLVGAPLDERTPSLPLASPQIVGLPAGLPSALLQRRPDILEAEHQLRAANADIGAARAAFFPSISLTANAGSSSRELSGLFDGGTGTWLFQPQINLPLFTAGSLRASLDYARLQKEIEVARYEKSIQGAFQEVSDGLAARATYERQLVAQRDLVASTQRYYDLARNRYRIGVDSSLTFLDAQRSLFSAQQGLINDRLAQLLAEVNLYAALGGGWKDAQ	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	95.88	gnl|BL_ORD_ID|2355|hsp_num:0	1305			18	1404	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
BGC0000462.1|WLIP_3 # 2530 # 3294 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.647	BGC0000462.1|WLIP_3 	2530	3294	-	Loose	540	26.1794	OXA-157	24.24	3001462	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGCTGACCCGCAGCCTCGAACATCACCACGACGCGCGCCTCTACCTGCAACTGGGAGAACTGATCGCCAGCACCGGCGAGATTCATTTTGCCGAGCGCATGCTCCAATTGGTCGACAGCCTCGTGCCGATTCACCGGCTCGACCTGAGCGAGTGGACCCTGGATGCCCGACAGACCGGCGTCACCCGGGTCAAGGTGCTGGGCGGCGCAGGGCTGGCCCAGGAGTTTCCTCCGCCTGATCAGCCCAATCACCCGCTGTTGCAGAACATTCTGCAGATGAAGGATCCCCTGCTCATTCAGGTCAGGGCGCCGCATGTCACCGGCAACCCGCAACCCAGCGCGCACCAGTGCAACCTGGTGTCATGCAATGGCGACCGCCGTTGGGTCATCTGCTTCCATCGCCCGCCCAGCCAGACAGCCTTTTCCCTCGGCGAACTGTCGCTGCTCAAGCGCCTCTCCGACACCCTGTTGCCCTTGCTCGAACACCATGCACAACACCCGGTGCACGGCCAGGGCGAAGGCGCGGCGATGCCCGATGCGTTGCGCCACGGCTTCGGCGAGCGCCTGGCCCAGGAAGCGGTGCAACTGTCGAGTCGCGAGCAGGAAGTCTGCCTGGGGCTGCTCACCGGCGGCACCGTGCCGGAAATGGCCCAACGCCTGAACGTGAAGAACAGCTCAGTGGAAACCTACCTCAAACGCGCCACCGCCAAGCTTGGCGTCAGTGGCCGCCACGGCCTGGCCAGATGGATGGCCGGTGCCTGA	MKLTRSLEHHHDARLYLQLGELIASTGEIHFAERMLQLVDSLVPIHRLDLSEWTLDARQTGVTRVKVLGGAGLAQEFPPPDQPNHPLLQNILQMKDPLLIQVRAPHVTGNPQPSAHQCNLVSCNGDRRWVICFHRPPSQTAFSLGELSLLKRLSDTLLPLLEHHAQHPVHGQGEGAAMPDALRHGFGERLAQEAVQLSSREQEVCLGLLTGGTVPEMAQRLNVKNSSVETYLKRATAKLGVSGRHGLARWMAGA	MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEGAKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVDNSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDIGWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI	89.12	gnl|BL_ORD_ID|2590|hsp_num:0	3421			537	732	cloxacillin; oxacillin; cefalotin
BGC0000462.1|WLIP_4 # 3709 # 10056 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.667	BGC0000462.1|WLIP_4 	3709	10056	+	Loose	1000	122.865	almE	26.73	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCCTGCCGCCGATACCTACCCCCTGACCAGTGCTCAACGGGACATCTGGCTCGACCAGTTGAGCAAAGGCGATTCTCCGCTCTATACCATCGGCGGCTATGTCGAACTCACGGGCGAGCTGCGGCCGGACACCCTGCATCACGCGTTGCAGCAACTGGTGGCGGCCAACCCGGTGTTGCGCACCGAGCTGCTGCCAGGTGCAGGTGCCGACGGCCTGCCGATGCAGCGCTTCGCCGAGCATGCCACGTTGGCGTTGCCTGTGCTGGACCTGTCGACTGAAGCCGACCCGGCAGCCGCGGCCACGGCATTGATTCAGGCGCAAATGGGCCAGGGGTATCGCTTCGACGGCACGGCACTGCTGCGTTTCGCCCTGATTCGCCTGGGCCCCGAACGTCATTGGCTGGCAACCCAGGCCCACCACCTGATCCTCGACGGCTGGGGTTTCGGGCAGATGCTCAAGGCACTGGGCGAGCATTACACGGCGCTGCTCGAGGGTGGCGAGGCGCCACGGGCCCAGGTCGGTTATGCCGACTTCATCGACGAAGACCGCCAGTACCAGGGCTCGATGCGCCAGGCCCGCGATCGCGCATATTGGCTCAAGCGCTTCGCCAGTGTGCCGGAGCCGCTGCTGGCAGCGCGTCACCATTACCGTCGAGCCACCGATGAAGCACCTTCGCGCACCTGGGTTCAGGCGTTTCCCGATGCGTTGCATGGGCGCATGAAGCGCCTGGCCGAGGCTCACCAGGCCTCGGCGTTCCATGTCCTGCTGGCTGCACTGCATGTGCTGTTCTCCCGCAGCGCACAACGCGAGGACTGGGTGGTGGGGCTGCCGCTGCTCAATCGTGGCGGTGCACGTTTCAAGGCCACGCTGGGGACCTTCGTGCAGGTCAGTGCGGTGCCCCTGGCGTTTGCCCCGACACTGAGCTTCGCCGAACTGGTGGTTGCGATACGCGATACCCTGCGCCGGGATTTTCGCCATCAGCGACTGGCCGTGAGCGAGCTGAACCGAGCGCTTGGCCTGTTGCGCGAGGAACGCGGGCAATTGTTCGAGGTGTCGGTCTCCTACGAGCAGGACGATCACGACTACCGCTACGGCGAGGCCAGCGCCCACACGGTGAAGGTCTCCAACAGCCACGAATCCACGCCCTTGGCCATCCACCTGCGCAGCAATCGCCATAATGACAAGGCGTGGTTGCATCTGGTGCATCACCGCGCCTGGCTGGCAAGCGAGGAGGCCGAGGCGTTGGCGCAGCGGCTGCTGCATATGCTCGACCAAGGCTTGGCGACACCGGCGTTGGCGGTTGCCGATTTCGACCTGCCGACACCTGCCGAGCATCGCCAGATGCAGGCGTGGAATGCGACGGGGCGCGCCGTTGGCGAGCCGGTCGTGCACCGCCGGATCGAGGCCCACGCGGCGCTGATGCCCGACGCCATTGCCGCTGTGCACGAAGGGCGCAGCCTGAGCTATGGCGAGCTGAATCAGCGGGCAAATGCTCTGGCCCTGCGTCTGATCGAACGAGGTGTGAGGCCCGAGCAGCGCGTGGCAGTGGTTGCCCGCCGTGGCCTGGATACCCTTGTGGGCCTGCTGGCGATACTCAAGGCGGGGGCAGCCTACGTACCGATCGACCCGGCGCATCCGCGCGAGCGCATCGCATATCTGCTTGAAGACAGCGCGCCCGTGGTACTGCTGACACAACAGGACCTGCTGGCGCGTCTGCCGCGCCATGAGCTGCCGCTGATCGAACTCGACGCCTGCCCGGCAGCCACGACCATTGTGGACAACCCTCGCGTGGCGGGGCTTGGGCCCGAGAGCCTGGTCTATGTGATCTACACCTCAGGCTCCACTGGCCAACCCAAGGGGGTGATGGTCGAACACCGCATGCTGGCCAACCTGGTCGATTGGCATTGCGAGGCCTTTGACCTGGGCGTCGGCGGGCACACGTCGAGCCTGGCCGGCTTTGGTTTCGATGCCATGGCCTGGGAGGTCTGGCCAGCCTTGTGTGCGGGGGCGACGCTGCACCTGGCGCCCAGCAGCGACGGTGGCGAAGATATCGACAACCTGCTGCGCTGGTGGCGTGCCCAGCCACTGCAGGTCAGTTTCCTGCCAACCCCGGTGGCCGAACACGCGTTCACCCAGCACGATCACCCGACCCTGCGTACCCTGCTGGTGGGGGGGGATCGGCTGCGCAGCCTGTCGCGTGAGCGGGCGTATGCGGTCATCAACAACTACGGCCCTACCGAAGCCACGGTGGTCGCCAGCTCCGGGCGGGTGACGGCGGGTGGTGCGCTGCATATCGGCACGCCTGTGGCCAATACCCGGCTGTATGTGCTCGATGCGCAGCTCAAGCCATTGCCGGTCGGTATCCCGGGCGAACTCTATGTAGCAGGCCTGGGGGTCGCCCGCGGCTACCTTAATCGCCCGCAGATGACCGCCGAGCGTTTCCTCGACGACCCGTTCAGTGAAGAGGTCGGTGCCCGGATGTACCGCACCGGCGACCGCGTGCGCTGGCTTGCCGACGGCACCCTGGAGTACCTGGGGCGCAATGACGATCAGGTGAAGATTCGCGGTGTACGCGTCGAACTCGGTGAGATCGAGGCTGCGCTGACCCGTCACCCGCAGGTGCGCGAAGCGGTGGTGCTGCTGCGCGATGGGCAACTGCAAGCCTGGTTCATTGGCGATGCGGTTACCCCCGGCGACCTGCATGAGCACCTGCGCGGGCTTCTGCCGGTGGCCTTGCTGCCAGCCGGCTACCAACGCATCGAGCACTGGCCGTTGACCGCCAACGGCAAGCTCGACCGTCGCGCCTTGCCGGCGCTGGATGAAACCGCATCGGTACGTCGCGCCCATGAAGCGCCTCGCGGCGACGTGGAGGTTCGCCTGGCTGCGCTCTGGAGCGAACTGCTGGGTGTGCAGCGCATTGGCCGTCACGACCACTTCTTCGAGTTGGGTGGCCATTCGTTGCTGGCGGTGCAACTGGTCGAACGCATGCGCCAGCAGGGCCTGCAGGCTGACGTGCAGGTGCTGTTCGGCCAGCCGACCCTGGCAAGCCTGGCCGCCGCCAGCCAGCGTCTGCTCGCGCAGGTGGAGGATAACCGCGTACCCGCTGACTGCACCCATATCACACCGGCGCTGCTCAGCCTGGCTTCGCTGACCCAGGGCGAGATCGACGCCATTGTCGCGGGCATACCGGGTGGCGCAGGCAATGTGCAGGAAATCTACCCCTTGGCGCCATTGCAGCAGGGGCTGCTTTATCACCACCTGCGCGACAGCCATGACCCTTATCAGCAACAGGCGCTGTTCGCCTTTACCGACCGCACGGCGTTCGAGGCATTTGCTCACGCGTTGCAGCAGGTGGTCGAGCGTCACGACATCCTGCGCACCAGCCTGGCTTGGGAAGGGCTCGAGCAACCGCAGCAAGTGGTCTGGCGTCAGGCGCAACTGCCCGTCGAGGTGTTGCGGATCGGGCCGGGCGACACGGCGCAGGAGTTGTCTGCACATTACTCAGCGGCCCAGCGCCCGCTGGACCTGCGTCATGCGCCGATGATGGCGCTGGCGGGGGCTGAAGACCGTGAGCACGGTCGTTGGCTGGGGTTGTTGCGCTTCCACCATCTGGTCAACGATGCGGTGTCGGTGCAGGTGTTGCTCGGCGAGCTTCGGGCCTTGATGAGCGATCAGGGGCATGCGCTGCCGGCGCCTGTGCCTTATCGCAACTACGTCGCGCTCAGCGGCGCCGAGGTGCGGCAGCAAGGGCACGAGGTGTTCCTGCGGGCATTGCTGGCAGGTGTCGAGGCACCGCCGACGTTGCCGGGGATAGTAGAGGACCAGGTGCAGGCGGACGCGCTGGAGAGCCTCGCGCATGAGGCTCCGCTGGTGCTGACCGAGGCCTTGCGCCGCCTGGCCAGGCAGCAGGATGTCGGGCTGGCCAGCCTGTTCCACCTGGCTTGGGCGCAGGTGCTGGGGGCACTGGGCGGTCGTGACGACGTGGTGTTCGGCAGCGTGTTGCTGGGGCGGATGATGGCGGGTGAGGGGGCCGACCGAGCGTTGGGCATGTTCATCAACAGCTTGCCCCTGCGGGTGAGCCTGGCGGGGCGCAGCGTGGCGCAGGCGCTGGCCGACACCCATGCCGGCCTTGCCGGGCTGTTGGGCCATGAAGACGCACCCTTGCTGCTGGCCCAGCGTTGCAGTGGGCTGCCAGCGGGTGTGCCGCTGTTCAATAGCCTGATCAATTTCCGCCATGGGCTGGCGGCCGAACAATCGACGTTGCCAGGGGCTCGCTTGTTGGAGGCCAGCGAAGTACACAGCCATGCGCTAGTGCTGTCGGTGGATGATCAGGGTGAGGCCTTGCACCTGAGCGTTCGTGCGCCGCGAGCATTGGGTGCAGCGCGTGTGCTGGCCTATCTCGAACGTACCCTCGAGGGGCTGGCCGAGGCGCTGGAGCAGGGTGGTTCGGCACCGATCGAGCAGTTGTGCAGTGTGCCGGAGAACGAGCTGCACCGGCTGCTGCACGACTTCAATGCCACCGAGGAGCCCCATGAATTGATGCACAAGACCCTGCCGGCGCTGTTCCAGGCCCAGGTGCTGCGCACGCCCGATGCCGTGGCGCTGCAGACCGACGAGGCGACGCTGAGCTACCGTGAACTCGACGAGCAGGCCAACCGCCTGGCCCATCACCTGGTGGCCCTGGGCGTACAGCCTGACACGCGAGTCGGCGTCTGCATCGAGCGCGGCCTGTCGCTGCTGGTCGGGCTGCTGGGCGTGCTCAAGGCCGGCGGTGCCTACGTGCCGCTGGATCCTGGTTACCCGGATGAACGCCTGCGCTACATGGTCGAGGACAGTACACCGCTGGCAGTGCTGGTCCACGGGGCCACACGTGGCCTGTTCGATCCGTTGGCGGTGCCGCTGGTGGATCTCGATCAGGGTGTCTGGCAAGCGCAGCCTGCCCAGGCCCCTCAGGTGCCGACACTGACGCCTTCGAACCTTGCCTACGTGATGTACACCTCCGGCTCGACCGGCATGCCCAAGGGCGTGATGATCGAGCACCGCGGGCTGGGCAACCTCATGCACTGGGGCTCGACCATCTGCCCGCCGCGTCCGGGCGATGCGCTGTTGCAGCGTGCGCCGTTCAGCTTCGACGGTTCGGTCTGGGAGTTGTTCTGGCCGTTGTGCGCAGGCTTGCGCCTGGTGCTGGCCCGCCCTGACGGTCATCGCGATCCGGCTTACCTGGTCCAGCTGGTCCAGGCTCGCCAGGTCACCACGATCAAGTTCGTCCCGGCATTGTTGCACCAGTTTCTCGAGCAGCCGGGCGTCGAACGCTGTACGAGCCTGACCGACATCTTCTGTGGCGGGGGGGAGTTGACCTTGACGCTGACTGCCAGCTTGCGCCAGCGCCTGCCGCAGGTGCGCTTGCACAACGTTTATGGGCCCACCGAGGCTACGGTCGACAGCACGGCCTGGACGCTCGAACCGGATCAACCGCTGCCGAGCACGCCACCGCCGATCGGCCGGGCGATCGCCAACACCCGGCTCTACGTGCTGGATGCCCATGATCGGCCGGTGCCACTCGGCGTGGCAGGTGAGTTGCACATCGGCGGCGTCGGTGTGGCACGCGGCTACCTGGGGTTGCCGGTGCTGCAGGCCGAGCGCTTCATCGACAGCCCGTTCGTCGAGGGCGATCGGCTGTACCGCACCGGGGACCTGGTGCGCTACCGCGAGGATGGCGAGCTGGAGTTCCTCGGGCGCAACGACTTCCAGGTCAAACTGCGTGGTCTGCGCGTAGAGCTGGGTGAGATCGAGGCCCTGCTGGCCGGGCATCCCGCTGTGGGCCAGAGCGTGGTATTGGTGCGCGACGAGCGTCTGGTCGCCTACTTCACCTGCCGGGAGGGGCAACCCGCCCCGGCACTGGATACGTTGCGCAGCCACCTGCTGGCGCGGCTGCCGGAGTACATGGTGCCCTCGGCCTTCGTCGCCCTGGCCGACATGCCGCTCAGCCCCAACGGCAAGATCGACCGCAAGGTGCTGCCTGAGCCTGGAGCGGAATCGGTGATCAGCCGCGTCTACACGGCGCCACGCAACGCACTGGAGCAGACCCTGGCGCAGATCTGGAGCGAGGTGCTGAAGGTCGAGCAGGTTGGGCGGGACGACAACTTCTTTGAACTGGGCGGGCATTCACTGCTGGCGGTGAATCTGGTGGCGCGCATGCGCCAGGCGGGGTTGCAGGCCGACGCACGTACCTTGTTCCGCCAGCCCACGTTGGCGGGCCTGGCGGCCAGTACCGGGTGGGACAAGCCGCAGGTCGAGATCGCGGCCACCACCATCCCGGGGCTGAAGGCACGAGGCAGGATCTGA	MPAADTYPLTSAQRDIWLDQLSKGDSPLYTIGGYVELTGELRPDTLHHALQQLVAANPVLRTELLPGAGADGLPMQRFAEHATLALPVLDLSTEADPAAAATALIQAQMGQGYRFDGTALLRFALIRLGPERHWLATQAHHLILDGWGFGQMLKALGEHYTALLEGGEAPRAQVGYADFIDEDRQYQGSMRQARDRAYWLKRFASVPEPLLAARHHYRRATDEAPSRTWVQAFPDALHGRMKRLAEAHQASAFHVLLAALHVLFSRSAQREDWVVGLPLLNRGGARFKATLGTFVQVSAVPLAFAPTLSFAELVVAIRDTLRRDFRHQRLAVSELNRALGLLREERGQLFEVSVSYEQDDHDYRYGEASAHTVKVSNSHESTPLAIHLRSNRHNDKAWLHLVHHRAWLASEEAEALAQRLLHMLDQGLATPALAVADFDLPTPAEHRQMQAWNATGRAVGEPVVHRRIEAHAALMPDAIAAVHEGRSLSYGELNQRANALALRLIERGVRPEQRVAVVARRGLDTLVGLLAILKAGAAYVPIDPAHPRERIAYLLEDSAPVVLLTQQDLLARLPRHELPLIELDACPAATTIVDNPRVAGLGPESLVYVIYTSGSTGQPKGVMVEHRMLANLVDWHCEAFDLGVGGHTSSLAGFGFDAMAWEVWPALCAGATLHLAPSSDGGEDIDNLLRWWRAQPLQVSFLPTPVAEHAFTQHDHPTLRTLLVGGDRLRSLSRERAYAVINNYGPTEATVVASSGRVTAGGALHIGTPVANTRLYVLDAQLKPLPVGIPGELYVAGLGVARGYLNRPQMTAERFLDDPFSEEVGARMYRTGDRVRWLADGTLEYLGRNDDQVKIRGVRVELGEIEAALTRHPQVREAVVLLRDGQLQAWFIGDAVTPGDLHEHLRGLLPVALLPAGYQRIEHWPLTANGKLDRRALPALDETASVRRAHEAPRGDVEVRLAALWSELLGVQRIGRHDHFFELGGHSLLAVQLVERMRQQGLQADVQVLFGQPTLASLAAASQRLLAQVEDNRVPADCTHITPALLSLASLTQGEIDAIVAGIPGGAGNVQEIYPLAPLQQGLLYHHLRDSHDPYQQQALFAFTDRTAFEAFAHALQQVVERHDILRTSLAWEGLEQPQQVVWRQAQLPVEVLRIGPGDTAQELSAHYSAAQRPLDLRHAPMMALAGAEDREHGRWLGLLRFHHLVNDAVSVQVLLGELRALMSDQGHALPAPVPYRNYVALSGAEVRQQGHEVFLRALLAGVEAPPTLPGIVEDQVQADALESLAHEAPLVLTEALRRLARQQDVGLASLFHLAWAQVLGALGGRDDVVFGSVLLGRMMAGEGADRALGMFINSLPLRVSLAGRSVAQALADTHAGLAGLLGHEDAPLLLAQRCSGLPAGVPLFNSLINFRHGLAAEQSTLPGARLLEASEVHSHALVLSVDDQGEALHLSVRAPRALGAARVLAYLERTLEGLAEALEQGGSAPIEQLCSVPENELHRLLHDFNATEEPHELMHKTLPALFQAQVLRTPDAVALQTDEATLSYRELDEQANRLAHHLVALGVQPDTRVGVCIERGLSLLVGLLGVLKAGGAYVPLDPGYPDERLRYMVEDSTPLAVLVHGATRGLFDPLAVPLVDLDQGVWQAQPAQAPQVPTLTPSNLAYVMYTSGSTGMPKGVMIEHRGLGNLMHWGSTICPPRPGDALLQRAPFSFDGSVWELFWPLCAGLRLVLARPDGHRDPAYLVQLVQARQVTTIKFVPALLHQFLEQPGVERCTSLTDIFCGGGELTLTLTASLRQRLPQVRLHNVYGPTEATVDSTAWTLEPDQPLPSTPPPIGRAIANTRLYVLDAHDRPVPLGVAGELHIGGVGVARGYLGLPVLQAERFIDSPFVEGDRLYRTGDLVRYREDGELEFLGRNDFQVKLRGLRVELGEIEALLAGHPAVGQSVVLVRDERLVAYFTCREGQPAPALDTLRSHLLARLPEYMVPSAFVALADMPLSPNGKIDRKVLPEPGAESVISRVYTAPRNALEQTLAQIWSEVLKVEQVGRDDNFFELGGHSLLAVNLVARMRQAGLQADARTLFRQPTLAGLAASTGWDKPQVEIAATTIPGLKARGRI	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	380.40	gnl|BL_ORD_ID|4935|hsp_num:0	5928			135	1635	colistin A; colistin B
BGC0000462.1|WLIP_5 # 10174 # 10797 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.660	BGC0000462.1|WLIP_5 	10174	10797	+	Loose	1500	26.1794	rphB	30.0	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGGACCTGTCGAGCCTGCTGCTGTTCATCCCCGCCTGTTTCGCCCTGAACATGGCGCCGGGGCCTAACAACCTACTGTCGCTGCACAACGCCAGCCGCCACGGCTTGCGCACTGCCTGCCTGGCAGGGGGCGGGCGTATCCTCGCCTTCAGCGGCATGATCACCTTGGCGGCGATGGGGCTGGCGGTGGTGCTACATACCAGCGAATACCTGTTCCTGAGCATCAAGCTCATGGGCGCGGGCTACCTGTTCTATATCGCCTGGCAATTGTGGCGGGCGCCCGTGGCAGAGGTGGCCCATGCCGGCGGGCAGTCGCGCGGCACCTGGAGCCTGGCACGCCAGGAGTTCTGGGTGGCGGCGGGCAACCCGAAAGCGATCCTCATATTCACCGCCTTCCTGCCGCAGTTCGTGTCGGTCGGCAGTACCACCCCGGTGAGCGAGCAGTTCCTGTGGCTGGGGTTGTGGTTCCTGTTGCTGGAATGGGCGGCGATCGCGATCTATGCGGCGCTGGGTGCCTACCTGCAGCGCTGGTTCAACCAGCCGCGGCCACGGCGGCTGTTCAACCGGATCAGCGCATCGTTGCTGGGATGCGCAGGGCTTGGCTTGCTGGCGGCGCGGCGATAG	MDLSSLLLFIPACFALNMAPGPNNLLSLHNASRHGLRTACLAGGGRILAFSGMITLAAMGLAVVLHTSEYLFLSIKLMGAGYLFYIAWQLWRAPVAEVAHAGGQSRGTWSLARQEFWVAAGNPKAILIFTAFLPQFVSVGSTTPVSEQFLWLGLWFLLLEWAAIAIYAALGAYLQRWFNQPRPRRLFNRISASLLGCAGLGLLAARR	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	23.42	gnl|BL_ORD_ID|2235|hsp_num:0	2528			858	1056	rifampin; rifaximin; rifabutin; rifapentine
BGC0000462.1|WLIP_6 # 10815 # 12017 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.658	BGC0000462.1|WLIP_6 	10815	12017	-	Loose	500	37.3502	bcr-1	27.11	3003801	protein homolog model	n/a	n/a	bicyclomycin-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCGACAACTACCGCCTGGCCCGCTACGCCTTGTATCTGCTGTTTCTGCTCCCTGGCCTGACCCTCGCCAGCTGGGTCACCCGCACCCCTGCCCTGCGCGACGGCCTGTCGGCCTCCACCGAACAGATGGGGATGATCCTGTTCGGATTTTCAGCCGGAGCGATGTGCGGGATTCTCAGTGCCGGACGCCTGATCGCCCGCTTTGGTGCACACCGGATGATGCGCACCGGCCTGCTCGGGCTGTCCGCAGGCATGCTGGTGCTGGCCGGCAGCAGCGAGTTGAACAGTGCCTGGTGCGCCTTTGCCGGGCTGTTCATCTACGGCATCGGCATGGGTTGGGCGGATATCGCAGTGAACATCGAAGGTGCAGCCGTGGAGCGGGAAATCGATGCACCGATCATGACTACCCTGCACGGTTTCTTCAGCCTCGGCACCCTGGTGGGCGCGCTGGCCGGCATGGGCATGACCGCGCTGCAGGTGCCCCTGGACCTGCATCTGATCGTCGCCGCACTGCTTTCGGCCGTGGTGACCCTGGCCCTTGCCCCTCACGCCCCTCGGGCCAGTGAAGGAGCAGCGAATCAACCGACAACGCAGACAGCCGAGTTTGCCTGGGGCGCCCTGCTCAGCGACCGACGCCTGTTGCTGATCGGCTTCGTGGTGCTGGCCATGGCGCTGGCCGAGGGTGCAGCCAATGACTGGCTGCCGCTGCTGATGATCGACGGCCACGGATTCGCAGAAACCACCGGCACGCTGATCTACCTGGTATTCACCCTGGGCATGACCCTGGGTCGATTCGCCGGTGCGCCGGTGGTGCGCCGCTTTGGCCGGACGCTCACCTTGCGCGCCAGCGCACTGCTTGGCGCAGCCAGCCTGGCATTGGTGGTGTTCTGCGACGTGCAGTGGATCGCCGCAGCCGCCGTGATGCTCTGGGGCATTGGCGCATCGCTGGGTTTTCCCCTGGCGATCTCGGCAGCCGGGGAAAGTGGTGCTCACAGCGATCAACGCGTCAGGCTGGCAGCAACGGCAGGTTACCTGGCGTTTCTGGTCGGCCCGCCCCTGCTGGGCTTTATCGGCGAACATCATGGCTTGCGCCTGGCGATGCTGCCGGTCCTGACACTGGTGGCCCTGGCGTTCGTCGTGGCGTCGGCGCTGCGCGAGCAAGCCGCTTTGCCTGTCGATACCTGCGAAAAGACCGGTTGA	MPDNYRLARYALYLLFLLPGLTLASWVTRTPALRDGLSASTEQMGMILFGFSAGAMCGILSAGRLIARFGAHRMMRTGLLGLSAGMLVLAGSSELNSAWCAFAGLFIYGIGMGWADIAVNIEGAAVEREIDAPIMTTLHGFFSLGTLVGALAGMGMTALQVPLDLHLIVAALLSAVVTLALAPHAPRASEGAANQPTTQTAEFAWGALLSDRRLLLIGFVVLAMALAEGAANDWLPLLMIDGHGFAETTGTLIYLVFTLGMTLGRFAGAPVVRRFGRTLTLRASALLGAASLALVVFCDVQWIAAAAVMLWGIGASLGFPLAISAAGESGAHSDQRVRLAATAGYLAFLVGPPLLGFIGEHHGLRLAMLPVLTLVALAFVVASALREQAALPVDTCEKTG	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	99.50	gnl|BL_ORD_ID|2332|hsp_num:0	2303			87	888	bicyclomycin
